NGT HealthCare II ("NGT") is an early-stage medical device and life sciences venture capital fund, investing in promising technologies. The fund focuses on creating value and investing in people with innovative ideas. A significant risk reduction mechanism is achieved through non-dilutive leverage via Israel’s Innovation Authority (IIA). NGT leverages close relationships with leading universities, hospitals, and research institutions in Israel to gain access to a rich flow of investment opportunities. A wide network with multinational corporations enables NGT to create value for its portfolio companies. NGT is structured as an impact fund, located in Nazareth, and aligned with 3 UN SDGs. The fund aims to expand its network and explore new opportunities continuously.
Bevorzugte Reifephase für die erste Finanzierung.
Medical devices, life sciences
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...